secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acrivon Therapeutics, Inc. (ACRV)
CIK:        0001781174
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001193125-26-007077
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Acrivon Therapeutics Provides Clinical Data Updates for ACR-368 and Initial ACR-2316 Data
--------------------------------------------------------------------------------

- On January 8, 2026, Acrivon hosted a webcast and conference call featuring ACR-368 clinical data and program updates.
- Initial clinical data for ACR-2316 were presented during the webcast.
- The presentation was posted on the company website at ir.acrivon.com under Investors & Media.
- Exhibit 99.1 to the 8-K filing contains the January 8, 2026 Data Update.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781174/000119312526007077/0001193125-26-007077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781174/000119312526007077/acrv-20260108.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-007077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer